Since its creation in 1929, Laboratoires Mayoly Spindler has embodied French pharmaceutical tradition and excellence. Founded by a couple of passionate pharmacists, this family-run business has evolved over the decades while remaining true to its values. Bought out in 1975 by Dr Jean-Marie Vernin, it has undergone a veritable transformation, becoming a key player in the fields of digestive health, dermocosmetics and public health.
Mayoly Spindler's history can be divided into three major development periods. It all began with the launch of Charlieu shampoos and the handover to Jean-Gilles Vernin, son of Dr. Vernin, who continued to develop the family heritage. Between 1982 and 2008, growth accelerated with strategic acquisitions, notably Laboratoires Galéniques Vernin and Rosa-Phytopharma, and the launch of iconic ranges such as Topicrem and Probiolog. Finally, since 2008, the company has strengthened its international positioning, under the impetus of Jean-Nicolas Vernin. This latest phase is marked by product diversification and the acquisition of well-known brands, such as Smecta, reinforcing the company's expertise in the gastrointestinal sector.
The very essence of Mayoly Spindler is based on fundamental values: responsibility, pragmatism and benevolence. These principles are at the heart of every strategic decision and guide the daily work of our 2,200 employees worldwide. Unlike many companies, Mayoly Spindler has managed to remain an independent structure, enabling it to invest in innovative projects with a long-term vision. This unique approach favours sustainable choices, geared towards continuous product improvement and patient satisfaction.
Mayoly Spindler's responsibility extends beyond the simple manufacture of healthcare products. The company is actively committed to preserving the environment, using environmentally-friendly production methods and manufacturing 86% of its products locally. This commitment to excellence is also evident in the company's rigorous quality control processes, guaranteeing reliable, effective products.
Despite its local roots, Mayoly Spindler has established itself as a global player, with a presence in over 100 countries. The company has conquered international markets while preserving its French identity. This expansion has been made possible by the opening of strategic subsidiaries, first in Belgium in the 1970s, then in Mexico, Russia and Spain, and more recently in Asia and China. Today, 65% of Mayoly Spindler's sales are generated abroad, testifying to the worldwide recognition of its products.
The company is also proud of its French industrial expertise, with five production sites located in France. These modern, high-performance facilities produce high-quality healthcare solutions, from softgels to dermo-cosmetic products. Every stage, from design to distribution, is mastered in-house, reinforcing Laboratoires Mayoly Spindler's reputation for reliability and excellence.
Unlike many players in the pharmaceutical sector, Mayoly Spindler has preserved its family independence, a key asset for its development. This autonomy guarantees strategic agility, enabling us to adopt a proactive approach to market developments. Thanks to its long-term management approach, the company invests in structuring projects that meet the needs of future generations.
This commitment is also reflected in the strategic acquisitions made in recent years. For example, the purchase of Beauterra and Pharmnature has enabled Mayoly Spindler to diversify its portfolio and position itself in buoyant segments such as phytotherapy and cosmetic hygiene. These investments testify to the laboratory's determination to remain at the cutting edge of innovation while meeting the expectations of modern consumers.
With its rich heritage and solid foundations, Mayoly Spindler is resolutely looking to the future. Its objective is clear: to become a global reference in the field of consumer health. To achieve this ambition, the company's strategy is focused on innovation, international development and strengthening its partnerships. Every product and every solution developed by Mayoly Spindler aims to improve the quality of life of patients, by bringing them concrete, accessible and reliable benefits.
From the outset, Mayoly Spindler has excelled in the design of medicines to improve everyday health. Its expertise extends to several fields:
Created in 1994, the Topicrem brand is the fruit of a unique family and scientific approach. Its launch was marked by the development of Lait Ultra Hydratant Corps, designed to meet the needs of sensitive skin. Today, Topicrem offers a complete range of products:
In 2016, Mayoly Spindler strengthened its positioning in medical diagnostics by acquiring Kibion. This division, now known as Mayoly Diagnostic, focuses on screening forHelicobacter pylori, a bacterium responsible for many gastric and duodenal ulcers. Thanks to state-of-the-art technologies, Mayoly Diagnostic offers :
Choosing Mayoly Spindler means opting for a brand that combines tradition, innovation and human commitment. Whether for pharmaceutical products, dermo-cosmetics or diagnostic solutions, the company guarantees impeccable quality and genuine expertise. With over a century of experience and a forward-looking approach, Mayoly Spindler is committed to taking care of your health, today and for generations to come.
